Verastem, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $38.00K, a 72.73% increase year-over-year.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $29.00K, a 45.00% increase year-over-year.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $22.00K, a 55.10% decline year-over-year.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $20.00K, a 28.57% decline year-over-year.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $51.00K, a 26.09% decline from fiscal 2024.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $69.00K, a 21.05% increase from fiscal 2023.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $57.00K, a 65.24% decline from fiscal 2022.
- Verastem, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $164.00K, a 9.89% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $38.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $51.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $22.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $69.00K 10-K · filed 2026-03-04 | |
| 2024-09-30 | $20.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $49.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $57.00K 10-K · filed 2026-03-04 | |
| 2023-09-30 | $28.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $29.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $164.00K 10-K · filed 2025-03-20 | |
| 2022-09-30 | $64.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $182.00K 10-K · filed 2024-03-14 | |
| 2021-09-30 | $106.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $76.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $407.00K 10-K · filed 2023-03-14 | |
| 2020-09-30 | $148.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $259.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $439.00K 10-K · filed 2022-03-28 | |
| 2019-09-30 | $439.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |